Published in J Pharm Sci on August 01, 2004
Clinical relevance of dissolution testing in quality by design. AAPS J (2008) 2.36
Application of gastrointestinal simulation for extensions for biowaivers of highly permeable compounds. AAPS J (2008) 1.05
Disintegration of highly soluble immediate release tablets: a surrogate for dissolution. AAPS PharmSciTech (2009) 0.92
Fast dissolving strips: A novel approach for the delivery of verapamil. J Pharm Bioallied Sci (2010) 0.88
Comparison of drug permeabilities and BCS classification: three lipid-component PAMPA system method versus Caco-2 monolayers. AAPS J (2010) 0.85
Permeation of four oral drugs through human intestinal mucosa. AAPS PharmSciTech (2009) 0.77
A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res (1995) 12.09
Bioanalytical method validation--a revisit with a decade of progress. Pharm Res (2000) 6.83
Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report. Eur J Drug Metab Pharmacokinet (1992) 2.88
Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord (2000) 2.81
Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J Pharm Sci (1997) 2.35
The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res (1997) 2.28
Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur J Pharm Biopharm (2000) 2.14
Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm Res (1998) 2.08
Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res (1996) 2.05
Contact allergy to gold in patients with gold-plated intracoronary stents. Contact Dermatitis (2005) 2.04
Validation of bioanalytical methods. Pharm Res (1991) 1.83
Patch test reactions to merthiolate in healthy young subjects. Br J Dermatol (1970) 1.79
5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter. Pharm Res (1998) 1.66
Correlation of transient vision loss with outer retinal disruption following intravitreal ocriplasmin. Eye (Lond) (2013) 1.64
Steady-state pharmacokinetics of delavirdine in HIV-positive patients: effect on erythromycin breath test. Clin Pharmacol Ther (1997) 1.64
Determination of therapeutic levels of metronidazole in plasma by gas-liquid chromatography. J Chromatogr (1973) 1.59
Unilateral eruption of endogenous eczema after hemiparesis. Acta Derm Venereol (1989) 1.49
[Postoperative delirium: risk factors, prophylaxis and treatment]. Anaesthesist (1999) 1.48
Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur J Pharm Sci (2001) 1.46
Review of global regulations concerning biowaivers for immediate release solid oral dosage forms. Eur J Pharm Sci (2006) 1.46
Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. J Pharm Sci (2000) 1.45
Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical response. Br J Psychiatry (1991) 1.42
Nickel allergy and hand eczema. Contact Dermatitis (1975) 1.40
In-vitro dissolution profile comparison: statistics and analysis, model dependent approach. Pharm Res (1996) 1.36
Targeted prodrug design to optimize drug delivery. AAPS PharmSci (2000) 1.36
Oral drug absorption enhancement by chitosan and its derivatives. Adv Drug Deliv Rev (2001) 1.36
A compartmental absorption and transit model for estimating oral drug absorption. Int J Pharm (1999) 1.35
Chitosan for mucosal vaccination. Adv Drug Deliv Rev (2001) 1.29
Melanocytes in nevi and melanomas synthesize basement membrane and basement membrane-like material. An immunohistochemical and electron microscopic study including immunoelectron microscopy. J Cutan Pathol (2000) 1.27
Parents' education and children's educational aspirations and achievements. Am Sociol Rev (1968) 1.27
Biowaiver monographs for immediate release solid oral dosage forms: ibuprofen. J Pharm Sci (2005) 1.26
Membrane topology of the human dipeptide transporter, hPEPT1, determined by epitope insertions. Biochemistry (1998) 1.23
Human postprandial gastric emptying of 1-3-millimeter spheres. Gastroenterology (1988) 1.23
Absorption potential: estimating the fraction absorbed for orally administered compounds. J Pharm Sci (1985) 1.21
Intracutaneous test reactions to tuberculin containing merthiolate as a preservative. Scand J Infect Dis (1971) 1.21
The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; an explanation for the double peak phenomenon. J Pharmacokinet Biopharm (1987) 1.20
Bio-International 92, conference on bioavailability, bioequivalence, and pharmacokinetic studies. J Pharm Sci (1993) 1.20
Moisture sorption kinetics for water-soluble substances. I: Theoretical considerations of heat transport control. J Pharm Sci (1983) 1.19
Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance. J Pharm Sci (1994) 1.19
Evaluation of orally administered highly variable drugs and drug formulations. Pharm Res (1996) 1.17
Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption. Adv Drug Deliv Rev (1996) 1.17
Social class, parental encouragement, and educational aspirations. AJS (1968) 1.17
Breaking of scored tablets: a review. Eur J Pharm Biopharm (2002) 1.16
Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia. Schizophr Res (2001) 1.14
Prediction of physical aging in controlled-release coatings: the application of the relaxation coupling model to glassy cellulose acetate. Pharm Res (1991) 1.14
Topically applied antifungal agents. Percutaneous penetration and prophylactic activity against trichophyton mentagrophytes infection. Arch Dermatol (1977) 1.14
Influence of physical aging on mechanical properties of polymer free films: the prediction of long-term aging effects on the water permeability and dissolution rate of polymer film-coated tablets. Pharm Res (1991) 1.13
Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). J Control Release (1998) 1.12
Griseofulvin levels in stratum corneum. Study after oral administration in man. Arch Dermatol (1972) 1.12
Phototoxic reaction to chlorpromazine as studied with the quantitative mouse tail technique. Acta Derm Venereol (1976) 1.12
Scaleup of immediate release oral solid dosage forms. Pharm Res (1993) 1.10
Liposomes as carriers for topical and transdermal delivery. J Pharm Sci (1994) 1.10
Dissolution testing as a prognostic tool for oral drug absorption: dissolution behavior of glibenclamide. Pharm Res (2000) 1.09
Evaluation of the bioequivalence of highly-variable drugs and drug products. Pharm Res (2001) 1.08
Pharmacokinetics of trimethoprim and sulfamethoxazole in normal subjects and in patients with renal failure. J Infect Dis (1973) 1.08
Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter. Pharm Res (1998) 1.07
Biowaiver monographs for immediate release solid oral dosage forms: acetaminophen (paracetamol). J Pharm Sci (2006) 1.07
Identification of formulation and manufacturing variables that influence in vitro dissolution and in vivo bioavailability of propranolol hydrochloride tablets. Pharm Dev Technol (1998) 1.06
HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans. J Pharm Sci (1996) 1.05
Single dose kinetics of thioridazine and its two psychoactive metabolites in healthy humans: a dose proportionality study. J Pharm Sci (1989) 1.04
Novel approach to the analysis of in vitro-in vivo relationships. J Pharm Sci (1996) 1.03
Biowaiver monographs for immediate release solid oral dosage forms: ciprofloxacin hydrochloride. J Pharm Sci (2011) 1.03
Developments in buccal drug delivery. Crit Rev Ther Drug Carrier Syst (1991) 1.02
Protein denaturation during freezing and thawing in phosphate buffer systems: monomeric and tetrameric beta-galactosidase. Arch Biochem Biophys (2000) 1.02
Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: a mathematical model. Pharm Res (1993) 1.02
Biology of membrane transport proteins. Pharm Res (1995) 1.02
The bioinequivalence of carbamazepine tablets with a history of clinical failures. Pharm Res (1992) 1.02
Coagulation and fibrinolysis in chronic panniculitis. Acta Derm Venereol (1970) 1.02
A thyromimetic that decreases plasma cholesterol levels without increasing cardiac activity. Nature (1987) 1.02
Bioavailability of carbamazepine from four different products and the occurrence of side effects. Biopharm Drug Dispos (1999) 1.01
In-vitro release from corticosteroid ointments. J Pharm Sci (1995) 1.01
Cutaneous reactions to merthiolate and their relationship to vaccination with tetanus toxoid. Acta Allergol (1971) 1.01
Assessment of value and applications of in vitro testing of topical dermatological drug products. Pharm Res (1999) 1.00
In-vivo buccal delivery of fluorescein isothiocyanate-dextran 4400 with glycodeoxycholate as an absorption enhancer in pigs. J Pharm Sci (1996) 1.00
Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines. Biomaterials (2002) 1.00
Bioequivalence of oral products and the biopharmaceutics classification system: science, regulation, and public policy. Clin Pharmacol Ther (2011) 1.00
Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal caco-2 cell monolayers. J Control Release (2000) 0.99
Niosomes as a novel peroral vaccine delivery system. Int J Pharm (1999) 0.99
Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches. Biomaterials (2001) 0.99
Scale-up of adhesive transdermal drug delivery systems. Pharm Res (1997) 0.98
Setting bioequivalence requirements for drug development based on preclinical data: optimizing oral drug delivery systems. J Control Release (1999) 0.98
In vitro and in vivo assessment of adenovirus 41 as a vector for gene delivery to the intestine. Gene Ther (1998) 0.98
Randomized, controlled trial of prescribing training in a South African province. Med Educ (2001) 0.98
Interactions of elastic and rigid vesicles with human skin in vitro: electron microscopy and two-photon excitation microscopy. Biochim Biophys Acta (1999) 0.98
Intermittent treatment of psoriasis with clobetasol propionate. Acta Derm Venereol (1978) 0.98
A peptide prodrug approach for improving bisphosphonate oral absorption. J Med Chem (2000) 0.98